Ellison's U Turn on Oracle Stock Sale Exposes Regulatory Rift The sudden cancellation of Larry Ellison's $7.
5 billion stock sale plan has brought attention to the differing approaches taken by US and European regulators when it comes to executives trading their company's shares.
This isn't just a matter of technicalities or nuances between two regulatory frameworks; it highlights the underlying values and priorities that govern corporate governance across continents.